VGXi Sign Deal to Manufacture DNA for the Consortium

Wednesday, May 14th 2008

Print this page

vgxi-logo.jpgVGXi Pharmaceuticals sign a multi-year production agreement with the United Kingdom Cystic Fibrosis Gene Therapy Consortium.

VGXi Pharmaceuticals (Houston, TX) today announced that the company has signed a multi-year supply agreement to provide plasmid DNA to support the ongoing toxicology and clinical trials of the United Kingdom Cystic Fibrosis Gene Therapy Consortium.

signing.jpg

Deborah Gill signing the contract with VGXi in Baltimore at the ASGCT.


 

A frozen vial of GL67A (left) and a frozen vial of pGM169 plasmid DNA (right)

 

Purifying mRNA from tissue samples.